Concepedia

Kevin Lou

KL

Statistics

Publications

11

Citations

6.1K

H-Index

10

Active since

2012

Affiliations

University of California, San Francisco(Current)

Howard Hughes Medical Institute

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, Berkeley

University of Pennsylvania

Kevin Lou is an author at University of California, San Francisco specializing in drug discovery, molecular biology, and life sciences.

Publications per year

2012–2022

11

Publications

11

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · Nature · 2020 · 4.9K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 456 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition

Keelan Z. Guiley, Jack W. Stevenson, Kevin Lou et al. · Science · 2019 · 238 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

KRAS <sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependencies

Kevin Lou, Veronica Steri, Alex Y. Ge et al. · Science Signaling · 2019 · 179 citations · Full text

Medicine, Molecular Biology, Oncology +17

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies

Kevin Lou, Yuemang Yao, Adam T. Hoye et al. · Journal of Medicinal Chemistry · 2014 · 91 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

1–5 of 11